Transcatheter Aortic Valve Implantation in Patients with Percutaneous Intervention at the Left Main Coronary Artery
|
Athanasios Kolyviras1, Georgios Georgiopoulos2, Dimitrios Oikonomou3,4, Vaios Tzifos1 1Interventional Cardiology Department, Henry Dunant Hospital, Athens, Greece2Cardiology Department, ‘Hippokration’ Hospital, University of Athens, Athens, Greece 3Cardiology Department, ‘Evaggelismos’ General Hospital of Athens, Greece 4Electronic correspondence: jimoik4@hotmail.com |
|
|
Transcatheter aortic valve implantation (TAVI) is recommended for the treatment of severe symptomatic aortic stenosis in high-risk patients. Candidates for TAVI may present with coexistent significant left main coronary artery (LMCA) disease. Accumulating evidence suggests that TAVI plus percutaneous coronary intervention (PCI) in LMCA represents a feasible option for treatment of these patients. However, timing of the procedure, the significance of LMCA |
lesion anatomy and type of transcatheter valve remain debatable factors. Herein is reported the successful use of TAVI after ostial LMCA PCI in two consecutive patients. Cohort studies with long-term follow up are warranted to upgrade the level of evidence for TAVI in patients with concomitant significant LMCA disease and severe aortic stenosis. The Journal of Heart Valve Disease 2018-19;28:67-69 |
| Transcatheter Aortic Valve Implantation in Patients with Percutaneous Intervention at the Left Main Coronary Artery | |
Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.
Purchase this Article
Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.
Website by CHP Design, London